Aadi Bioscience, Inc. — Form D

Aadi Bioscience, Inc. of MORRISTOWN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-11. The offering totals $72.5M, of which $72.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Brendan DelaneyExecutive OfficerPacific Palisades, CA
Neil DesaiExecutive OfficerRye, NY
Loretta ItriExecutive OfficerPacific Palisades, CA
Mohammad HirmandDirectorSan Diego, CA
Neil DesaiDirectorRye, NY
Emma ReeveDirectorNorfolk, VA
Behzad AghazadehDirectorNew York, NY
Baiteng ZhaoDirectorMORRISTOWN, NJ
Scott GiacobelloExecutive OfficerMORRISTOWN, NJ
Caley CasteleinDirectorSan Francisco, CA
Richard MarounDirectorMORRISTOWN, NJ
Bryan BallExecutive OfficerMORRISTOWN, NJ
Dave LennonDirectorMORRISTOWN, NJ
Dave LennonExecutive OfficerMORRISTOWN, NJ
David DornanExecutive OfficerMORRISTOWN, NJ
Karin HehenbergerDirectorMORRISTOWN, NJ
Anupam DalalDirectorMORRISTOWN, NJ
Lance ThibaultExecutive OfficerGaithersburg, MD
Karin HenebergerDirectorPacific Palisades, CA
Paul M WeissDirectorMadison, WI
Muneer SatterDirectorCincinnati, OH
Steven M PrelackDirectorCincinnati, OH
Anupam M DalalDirectorCincinnati, OH
Joseph GardnerDirectorCincinnati, OH
Joseph GardnerExecutive OfficerCincinnati, OH

Other filings by this issuer (4)

FiledFormOfferingSold
2025-03-18D$100.0M$100.0M
2021-09-10D$82.5M$82.5M
2021-09-10D$155.0M$155.0M
2017-03-30D$41.8M$41.8M

More